verapamil has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our results did not demonstrate a benefit derived from the treatment with verapamil upon the diastolic function in patients with acromegaly." | 9.10 | [Utility of verapamil in the treatment of diastolic dysfunction in patients with acromegaly]. ( Climent Payá, VE; Marín Ortuño, F; Martínez Martínez, JG; Picó Alfonso, AM; Sánchez Payá, J; Sogorb Garri, F, 2003) |
| "Our results did not demonstrate a benefit derived from the treatment with verapamil upon the diastolic function in patients with acromegaly." | 5.10 | [Utility of verapamil in the treatment of diastolic dysfunction in patients with acromegaly]. ( Climent Payá, VE; Marín Ortuño, F; Martínez Martínez, JG; Picó Alfonso, AM; Sánchez Payá, J; Sogorb Garri, F, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marín Ortuño, F | 2 |
| Climent Payá, VE | 1 |
| Picó Alfonso, AM | 2 |
| Martínez Martínez, JG | 2 |
| Sánchez Payá, J | 1 |
| Sogorb Garri, F | 2 |
| Domínguez Escribano, JR | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| Minnielli, S | 1 |
| D'Amico, C | 1 |
| Di Pietro, ML | 1 |
| Albini, C | 1 |
| Passeri, M | 1 |
| Liberale, I | 1 |
| Menini, E | 1 |
| Barbarino, A | 1 |
1 trial available for verapamil and Inappropriate GH Secretion Syndrome (Acromegaly)
| Article | Year |
|---|---|
[Utility of verapamil in the treatment of diastolic dysfunction in patients with acromegaly].
Topics: Acromegaly; Aged; Calcium Channel Blockers; Diastole; Female; Humans; Male; Middle Aged; Ventricular | 2003 |
2 other studies available for verapamil and Inappropriate GH Secretion Syndrome (Acromegaly)
| Article | Year |
|---|---|
[Remission following verapamil use in acromegalic patient with heart failure].
Topics: Acromegaly; Aged; Female; Heart Failure; Humans; Remission Induction; Verapamil | 1999 |
Calcium antagonists and hormone release. V. Effects of a calcium-antagonist (verapamil) on pituitary hormone release in hypersecretory states.
Topics: Acromegaly; Adolescent; Adult; Cushing Syndrome; Female; Humans; Hypogonadism; Hypothyroidism; Male; | 1987 |